Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Heterocycles useful as anti-cancer agents

Heterocycles useful as anti-cancer agents

US Patent 11225492 · Granted Jan 18, 2022

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Heterocyclic compound as CDK-HDAC double-channel inhibitor2025
Adenosine receptor antagonist2025
Heterocyclic comipound as CDK-HDAC dual pathway inhibitor2025
Verification method, electronic device, and non-transitory computer-readable sto2025
Highly active CSF1R inhibitor compound2023
Heterocyclic compound serving as FGFR4 inhibitor2022
Heterocyclic compound serving as FGFR4 inhibitor2022
Polycyclic compound acting as IDO inhibitor and/or IDO-HDAC dual inhibitor2022
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor2021
Heterocyclic compound as Syk inhibitor and/or Syk-HDAC dual inhibitor2021
Compound containing tricyclic heteroaryl group2021
Compound containing tricyclic heteroaryl group2021